CNPY2 in Solid Tumors: Mechanisms, Biomarker Potential, and Therapeutic Implications
Sayan Mullick Chowdhury1, Feng Hong1,2, Christian Rolfo1
1Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Biology
|February 26, 2025
Summary
Canopy FGF signaling regulator 2 (CNPY2) drives solid tumor growth by affecting key pathways. Further research is needed to explore CNPY2
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Canopy FGF signaling regulator 2 (CNPY2) is implicated in cancer development.
- CNPY2 promotes cell proliferation, tissue repair, and angiogenesis.
Purpose of the Study:
- To review the role of CNPY2 in solid tumors.
- To explore CNPY2's impact on cancer pathways and therapeutic potential.
Main Methods:
- Literature review of CNPY2's function in various cancers.
- Analysis of CNPY2's modulation of signaling pathways (p53, MYLIP, NF-κB, AKT/GSK3β).
Main Results:
- CNPY2 differentially affects tumor growth and progression in renal cell carcinoma, prostate cancer, hepatocellular carcinoma, and non-small-cell lung cancer.
- CNPY2 influences the tumor microenvironment, immune function, and metastasis.
- CNPY2 shows potential as a biomarker for cancer detection and prognosis.
Conclusions:
- CNPY2 plays a multifaceted role in solid tumor progression.
- Targeted therapies and diagnostic strategies involving CNPY2 are under investigation.
- Further research is essential to fully understand CNPY2's oncogenic mechanisms.
Related Concept Videos
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K